Dr. Duru | TalkMarkets | Page 4
Self Proprietor, Ahan Analytics, LLC
Contributor's Links: Ahan Analytics One-Twenty Two
Dr. Duru Ahanotu is a graduate of Stanford University with over fifteen years of experience doing analytic modeling, executing pricing strategies through price optimization, and implementing, developing, and selling enterprise software. He adds to this industry experience another five overlapping ...more

All Contributions

Latest Posts
49 to 64 of 76 Posts
T2108 Update – Quick Chart Updates Including Apple’s Doubly-Ominous Print
T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse.
T2108 Update – Excitement Under The Calm
T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse.
T2108 Update – A Surprisingly Strong August, Mixed Prospects For September, And A Critical Test For Twitter
Given the odds seem to favor a down month for September, I will be very inclined to switch bearish if T2108 hits overbought levels (70% or above). At the current pace, T2108 should hit overbought by the middle of September.
Forex Setup Week (August 31, 2014) – Critical Test Of QE2 Resistance For The U.S. Dollar
The dollar index continued climbing the upward trending channel between the first and second Bollinger Bands (BBs). Now, the dollar index faces an even more critical test: the presumed ceiling of a trading range that has held firm since last summer.
Don’t Call It A Comeback: King Digital Scratches For A Bottom, Amazon.com Rises Yet Again
Almost two weeks after a post-earnings implosion, KING is showing some signs of life. The stock may even be scratching its way to a (short-term?) sustainable bottom.
T2108 Update – S&P 500 2K Edition
T2108 has not made much progress since the last T2108 Update on August 19th. However, the S&P 500 (SPY) has. The bounce from oversold conditions continues in nearly a straight line.
Forex Setup Week: That Stubborn Australian Dollar
This week, the stubborn resilience of the Australian dollar (FXA) has my attention. The “Aussie” has continued to make gains against every major currency I follow…except for the U.S. dollar.
An Over-Extended U.S. Dollar And A Complete Reversal For Gold
The U.S. dollar (UUP) is at 11-month highs. The dollar index is finally showing the strength many expected from the beginning of 2014 in anticipation of strong economic numbers and subsequent rate hikes.
T2108 Update – A Gut-Check On Sentiment As The S&P 500 Rolls On
It was another strong day for the S&P 500 (SPY). For the fourth trading day out of the last five, the index closed at or near its high of the day. Since the resolution of a bullish divergence, the index has printed healthy gains on six of the last eight trading days.
T2108 Update – Distractions Removed, The S&P 500 Passes The Test
Can add to existing buys now that the S&P 500 has broken out above its 50DMA. Stop on a close below the 50DMA.
Forex Setup Week: Return Of The Franc
Last week’s edition of Forex Setup Week featured three major trends: a looming breakdown in the British pound (FXB), a fresh 200-day moving average (DMA) breakout for the U.S. dollar over the Canadian dollar (FXC), and a resilient Australian dollar.
T2108 Update – The S&P 500 Almost Passes The Test
It looked like the perfect confirmation of the bullish bounce from T2108 oversold conditions. The S&P 500 (SPY) gapped up over its 50DMA, sellers could only barely push the index back to the 50DMA for a minutes, and then the buyers began applying fresh upward pressure. But then...
T2108 Update – S&P 500 Faces Its First Big Test After Lifting From Oversold Conditions
Hold on further buys until/unless S&P 500 confirms a 50DMA breakout. Otherwise, aggressive trades can attempt a fade at 50DMA resistance. See below for more.
A Technician’s Wary Eye On Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc. may indeed have the $5B blockbluster liver drug that RBC Capital Markets claimed in hiking its price target on the stock from $425 to $500.
T2108 Update – The NASDAQ Clears An Important Hurdle And Prepares A Path For The S&P 500
My eyes are open wide after reviewing today’s closing metrics. T2108 put on a spectacular show surging from 28% to 34% that seems to confirm last week’s bullish divergence. I even have just one minor caveat for today.
The Canadian Dollar Hangs In The Balance Between Weak Jobs Growth And Strong High-End Housing Demand
Statistics Canada painted another disappointing jobs picture for the country. Instead of the 20,000 additional jobs expected by the “consensus” for June, the Canadian economy lost 9,400 jobs.
49 to 64 of 76 Posts